Richard Phillip Mattick

           Born in 1955. National of Australia. Professor of Drug and Alcohol Studies at the National Drug and Alcohol Research Centre, Faculty of Medicine, University of New South Wales; Professor of Brain Sciences, University of New South Wales; Principal Research Fellow, Australian Government National Health and Medical Research Council (2013-2017), and Registered Clinical Psychologist.

           Bachelor of Science (Psychology), Honours, Class 1, University of New South Wales, 1982; Master of Psychology (Clinical), University of New South Wales, 1989; Doctor of Philosophy, University of New South Wales, 1988; and Certificate in Neuroanatomy, Anatomy, University of New South Wales, 1992.

Director of Research, Australian National Drug and Alcohol Research Centre (1995-2001), and Executive Director, Australian National Drug and Alcohol Research Centre, Faculty of Medicine, University of New South Wales (2001-2009). Member, Australian National Expert Advisory Committee on Illicit Drugs (2002-2004), Australian National Expert Advisory Group on Sustained Release Naltrexone (2002-2004), Monitoring Committee of the Medically Supervised Injecting Centre for the New South Wales Government Cabinet Office (2003-2004), Australian Ministerial Council on Drug Strategy Working Party on Performance and Image Enhancing Drugs (2003-2005), Australian Government Department of Health and Ageing Expert Advisory Committee on Cannabis and Health (2005-2006), New South Wales Expert Advisory Group on Drugs and Alcohol for the New South Wales Minister of Health (2004-2013), Australian National Council on Drugs advising the Prime Minister (2004-2010), WHO/UNODC Technical Guidelines Development Group on Pharmacotherapy of Opioid Dependence (2004-2008), Australian Research Alliance for Children and Youth (2005-2015).

           Served on the editorial and executive boards of Drug and Alcohol Review (1994-2005), and as Deputy Editor (1995-2000) and Executive Editor (2000-2005). Assistant Editor of the international peer-reviewed journal Addiction (1995-2005). Editor, Cochrane Review Group on Drugs and Alcohol (1998-2003). Authored over 280 books, chapters in edited volumes on substance abuse, addiction and treatment, and peer-reviewed academic journal articles on those subjects. Recent articles include "Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence", "Young adult sequelae of adolescent cannabis use" and "The Pain and Opioids IN Treatment study: characteristics of a cohort using opioids to manage chronic non-cancer pain".

           Recipient of academic and research support from the Australian Government Department of Health; the New South Wales Government Department of Health; the Australian National Drug Law Enforcement Research Fund; the Alcohol Education and Rehabilitation Foundation; UNODC; the National Institute on Drug Abuse of the United States; the Australian Research Council; and the Australian Government National Health and Medical Research Council.

           Member of the International Narcotics Control Board (since 2015) [1]. Member of the Standing Committee on Estimates (2015-2016).



[1] Elected by the Economic and Social Council on 8 April 2015; re-elected by the Council for a five-year term (2017-2022) on 5 April 2016.

©1995-2018 International Narcotics Control Board